Australia's most trusted
source of pharma news
Thursday, 07 November 2024
Posted 7 November 2024 AM
After divesting a number of portfolios globally to invest in new areas of growth, Viatris has made cuts to its workforce - but insists the impact on the ANZ team is minor.
"Viatris will continue to evolve our model to ensure we best support our strategy and priorities across Australia and New Zealand," the company said.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.